Skip to content

Evaluating the Impact of the Intervention of a Pharmacist in the Operating Room on the Appropriate Use of Sterile Medical DeviceS

Pilot Study Evaluating the Impact of the Intervention of a Pharmacist in the Operating Room on the Appropriate Use of Sterile Medical Devices and the Economic Repercussions

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04423250
Acronym
OPTIBLOC
Enrollment
150
Registered
2020-06-09
Start date
2018-03-23
Completion date
2018-10-31
Last updated
2025-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Brief summary

assess the impact of the intervention of a clinical pharmacist expert in sterile medical devices

Interventions

OTHERimpact of the intervention of a clinical pharmacist with expertise in sterile medical devices on non-compliances related to the use of sterile medical devices

\- Failure to trace, Lack of product information, absence of product in the operating room

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \- The patient must be a member or beneficiary of a health insurance plan. * The patient is managed for scheduled surgery (full hospitalization or outpatient) in the UDG (Urology Digestive Gynecology) operating room.

Exclusion criteria

* \- The subject is in a period of exclusion determined by a previous study. * The subject is under judicial protection. * The subject (or his/her legal representative) has expressed his/her opposition to participate in the study. * The patient is undergoing emergency surgery in the UDG (Urology Digestive Gynecology) operating room. * It is not possible to give informed information about the subject. Translated with www.DeepL.com/Translator (free version)

Design outcomes

Primary

MeasureTime frame
identify compliance with the appropriate use of sterile medical devices1 day

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026